<HashMap><database>biostudies-arrayexpress</database><scores/><additional><submitter>Neha Srivastava</submitter><organism>Homo sapiens</organism><software>Not Applocable</software><software>Agilent Feature Extraction</software><software>Agilent Feature Extraction, Metabolist</software><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/E-MTAB-17484</full_dataset_link><description>Peripheral blood samples were collected from (Heavy metal exposer- Parkinson disease)HME-PD, (Heavy metal non-exposer- Parkinson disease) NHME-PD, and healthy controls. Total RNA was isolated and profiled using the Affymetrix GeneChip™ miRNA 3.1 Array. Arrays were hybridized, washed, stained, scanned, and raw data (.CEL files) were RMA-normalized for differential expression.</description><repository>biostudies-arrayexpress</repository><sample_protocol>Scaning - The array scanning and feature extraction protocol for microRNA (miRNA) microarrays involves laser scanning the hybridized slide, aligning a grid template, and quantifying fluorescent intensities</sample_protocol><sample_protocol>Sample Collection - Based on clinical assessments, 2 ml of blood was drawn from each of the 10 PD patients in the heavy metal exposure group and 10 PD patients in the non- heavy metal exposure group, with 5 healthy controls from the heavy metal exposure group residing in the North East region. Blood was collected from the superficial vein on the upper limb and subsequently frozen at -20°C for subsequent analysis.</sample_protocol><sample_protocol>Labeling - The research was conducted using Affymetrix miRNA 3.1, which contains probes for human mature and pre-miRNA hairpins. After creating and reverse transcribing antisense cRNA, dUTP was incorporated into the cDNA. The cDNA was broken up using apurinic/apyrimidinic endonuclease I and uracil DNA glycosylase.</sample_protocol><sample_protocol>Nucleic Acid Extraction - Using the TRIzol reagent (Invitrogen, Carlsbad, CA, USA), total RNA was extracted from the whole blood samples in each group with respective controls. A 2% agarose gel has been used to confirm the integrity of the RNA.  Following that, the RNA sample was kept at -80 for further experiments.</sample_protocol><sample_protocol>Hybridization - Affymetrix miRNA3.1 arrays were hybridized for 20 hours at 55ºC and 20 rpm of continuous speed rotation. Using fluorescently-labeled antibodies, the miRNA array was cleaned, collared, and scanned once more in search of hybridization signals.</sample_protocol><figure_sub>MIAME Score</figure_sub><figure_sub>Organization</figure_sub><figure_sub>Assays and Data</figure_sub><figure_sub>Processed Data</figure_sub><figure_sub>MAGE-TAB Files</figure_sub><figure_sub>Array Designs</figure_sub><data_protocol>Data Transformation - Normalized miRNA expression data were analyzed using the Metaboanalyst 6.0 (https://www.metaboanalyst.ca/MetaboAnalyst/ModuleView.xhtml), a comprehensive web-based platform used for metabolomics data analysis, visualization, and interpretation, and validated</data_protocol><omics_type>Metabolomics</omics_type><omics_type>Unknown</omics_type><omics_type>Transcriptomics</omics_type><omics_type>Genomics</omics_type><omics_type>Proteomics</omics_type><instrument_platform>Not Applicablre</instrument_platform><instrument_platform>Not Applicable</instrument_platform><instrument_platform>Affymetrix miRNA 3.1</instrument_platform><study_type>microRNA profiling by array</study_type><species>Homo sapiens</species><pubmed_authors>Neha Srivastava</pubmed_authors></additional><is_claimable>false</is_claimable><name>MiRNA expression profiling in Parkinson disease patients from Heavy metal exposer and non exposer group with respective control</name><description>Peripheral blood samples were collected from (Heavy metal exposer- Parkinson disease)HME-PD, (Heavy metal non-exposer- Parkinson disease) NHME-PD, and healthy controls. Total RNA was isolated and profiled using the Affymetrix GeneChip™ miRNA 3.1 Array. Arrays were hybridized, washed, stained, scanned, and raw data (.CEL files) were RMA-normalized for differential expression.</description><dates><release>2026-08-31T00:00:00Z</release><modification>2026-08-31T01:00:47.408Z</modification><creation>2026-08-14T12:35:16.615Z</creation></dates><accession>E-MTAB-17484</accession><cross_references><EFO>EFO_0002944</EFO><EFO>EFO_0003814</EFO><EFO>EFO_0000753</EFO><EFO>EFO_0003813</EFO><EFO>EFO_0005518</EFO><EFO>EFO_0003816</EFO><EFO>EFO_0003815</EFO></cross_references></HashMap>